Remedy
YC F25New York, US · Founded 2025 · Delaware LLC · 2 employees · Acquired · 1 known investors
Remedy provides AI agents that automate pharmacy workflows including prescription refills, inbound patient calls, and data entry within existing pharmacy management systems. The platform serves retail pharmacies and handles tasks such as e-script processing, refill requests, insurance inquiries, and appointment scheduling.
Founders & leadership· Y Combinator alumni (F25)
VS
Vishnu Sreenivasanin𝕏Founder/CEO
ND
Nikhil DevarajinFounder
SM
Sai Mandhanin𝕏Founder
JH
JONATHAN H. GROSSManager of Issuer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1.4MraisedAug 2015 · 9 investors · OtherRule 506(b)
▶$1.4MraisedAug 2015 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- JONATHAN H. GROSSDirector
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- First sale
- Aug 2015
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Remedy Science Closes $20M Series A to Expand Clinically Developed Product Line | Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trendsnutritionaloutlook.com · 2026
- Remedy Secures $20M+ to Scale Its Simplicity-First Challenge to Skin Care Complexity | Global Cosmetic Industrygcimagazine.com · 2026
- Dr. Muneeb Shah's Remedy Raises $20M Series A Round As Investors Double Down On Clinical Skincare | Beauty Independentbeautyindependent.com · 2026
- Remedy Science Raises $19M in Series A Fundingfinsmes.com · 2026
- Remedy Closes Series A Funding Round | Happihappi.com · 2026
- REMEDY Raises Series A Led by L Catterton to Modernize Dermatologist-Developed Skincarebusinesswire.com · 2026
